40.57
Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten
Visualizing Xenon Pharmaceuticals Inc. stock with heatmapsEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Xenon Pharmaceuticals Inc.’s volatility index tracking explained2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Will Xenon Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Movers & Daily Stock Trend Reports - newser.com
Will Xenon Pharmaceuticals Inc. stock maintain growth storyPortfolio Return Report & Technical Confirmation Trade Alerts - newser.com
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-10-13 08:53:34 - newser.com
Mirae Asset Global Investments Co. Ltd. Purchases 403 Shares of Xenon Pharmaceuticals Inc. $XENE - Defense World
Will Xenon Pharmaceuticals Inc. stock attract more institutional investorsWeekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Xenon Pharmaceuticals (XENE): Exploring Valuation After Recent Share Price Momentum - Yahoo Finance
Leerink Partners Remains a Buy on Xenon (XENE) - The Globe and Mail
Evaluating Xenon Pharmaceuticals (XENE): Is the Current Valuation Justified After Recent Share Price Momentum? - Sahm
Research Analysts Issue Forecasts for XENE FY2025 Earnings - MarketBeat
What is Bloom Burton’s Estimate for XENE FY2025 Earnings? - Defense World
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees - MSN
Will Xenon Pharmaceuticals Inc. stock attract ESG investorsDay Trade & Free Weekly Watchlist of Top Performers - newser.com
Is Xenon Pharmaceuticals Inc. stock attractive for income investors2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
Is Xenon Pharmaceuticals a Smart Investment After Its New Clinical Trial Partnership? - Sahm
What analysts say about Xenon Pharmaceuticals Inc stockInsider Selling Patterns & Budget Friendly Trading Strategies - earlytimes.in
Brokers Offer Predictions for XENE FY2026 Earnings - MarketBeat
Bloom Burton Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to "Strong-Buy" - MarketBeat
Xenon Pharmaceuticals’ (XENE) Outperform Rating Reaffirmed at William Blair - Defense World
Xenon Pharmaceuticals (NASDAQ:XENE) Given “Buy” Rating at Chardan Capital - Defense World
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
77,750 Options: Xenon Pharmaceuticals Grants Equity to Seven New Hires at $39.20, Oct 2, 2025 - Stock Titan
Xenon Pharmaceuticals' (XENE) Outperform Rating Reiterated at William Blair - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) Receives "Buy" Rating from Chardan Capital - MarketBeat
XENE: Chardan Capital Maintains Buy Rating with $55 Price Target - GuruFocus
Chardan Capital Maintains Xenon Pharmaceuticals (XENE) Buy Recommendation - Nasdaq
Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Biotechnology Innovator with a 38.93% Upside Potential - DirectorsTalk Interviews
Transcript : Xenon Pharmaceuticals Inc.Special Call - MarketScreener
Will Xenon Pharmaceuticals Inc. stock recover after recent dropJobs Report & Verified Swing Trading Watchlist - newser.com
Is it time to cut losses on Xenon Pharmaceuticals Inc.Market Growth Summary & Safe Capital Investment Plans - newser.com
Xenon Pharmaceuticals Inc. $XENE Shares Purchased by J. Safra Sarasin Holding AG - MarketBeat
Xenon Pharmaceuticals announces executive changes - MSN
HighMark Wealth Management LLC Has $817,000 Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. stock chart pattern explainedWeekly Volume Report & Low Risk Entry Point Tips - newser.com
Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat
Insider Selling: Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells 25,000 Shares of Stock - MarketBeat
Xenon Pharmaceuticals Hits Day High with Strong 9.94% Intraday Surge - Markets Mojo
Published on: 2025-10-01 07:26:08 - newser.com
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):